BackOncoSec Medical Overview

OncoSec Medical Research & Development

Research & Development expenses for ONCS.

Quarterly R&D Expenses

$4.65M
31.82% YoY

As of Jan 31, 2023

Annual R&D Expenses (TTM)

$21.77M
24.54% YoY

Trailing 12 months ending Jan 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)